Medtech Investment Outlook: In Health Care You Don’t Become A Unicorn Overnight
Executive Summary
The pandemic has shaken up investor priorities and changed the outlook for health care start-ups – or has it? Nooman Haque managing director, life sciences and healthcare at Silicon Valley Bank, gives his view of what has changed over the past year, and looks at future trends.
You may also be interested in...
VC View: Riding The Waves Of Asia’s Healthtech Explosion
Asia continues to gain attention for its healthtech innovation and adoption activity, and VC investors have seen the merits of a maintaining a focus on this newly emerging regional innovation hotspot, regardless of the pandemic.
UK Medicines And Medical Devices Act 2021 Passed Into Law
The duties of the new commissioner for patient safety have been prioritized in the UK’s Medicines and Medical Devices bill, which has been given Royal Assent.
‘A Divorce But We Weren’t Even Married’ – Swiss Medtech Expects No EU MRA Before May
A last-minute solution to the unresolved EU MRA issue is unlikely, so local manufacturers must prepare for Switzerland to be a “third country” to the EU after the MDR comes fully into force.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: